You have read all your free articles, to continue reading subscribe to read the rest of this content.
Novo Nordisk's Semaglutide demonstrates superior glycaemic control vs insulin glargine U100 in adults with type 2 diabetes shows a new study. Findings from a phase 3a clinical trial for semaglutide, an investigational glucagon-like peptide-1 (GLP-1) analogue, demonstrated that treatment with semaglAlready a subscriber Login You have read all your free…
The first cohort of 40 adults was enrolled in the company's Phase I study in Zambia. The study is part of a late phase development program in Africa funded by EDCTP with 7,4 million Euro. The program consists of two clinical trials and is initiated with a Phase I trial…
The European Council has decided upon a new regulation for clinical trials and in Sweden, the Medical Products Agency together with the six regional ethical review boards, missioned by the government, have made a proposal for a common collaboration structure. Today, according to the operative legAlready a subscriber Login You…
Prometic Life Sciences has announced that it has received Swedish Medical Products Agency (MPA) Clinical Trial Application (CTA) approval to commence a clinical trial of its plasminogen therapy in patients suffering from chronic tympanic membrane perforation (chronic TMP). The clinical trial is aAlready a subscriber Login You have read all…
